Non-Muscle Invasive Bladder Cancer (NMIBC)

The Key Things to Know:

Non-muscle invasive bladder cancer (NMIBC) affects the inner lining of the bladder and has not invaded the bladder muscle. It is often treatable with local (bladder-preserving) therapies, and long-term outcomes are excellent with proper surveillance and follow-up.

What It Is

Bladder cancer begins when abnormal cells grow in the bladder lining. NMIBC includes three main types:

  • Ta:** Confined to the inner layer

  • T1:** Grown into the connective tissue beneath the lining but not the muscle

  • CIS (carcinoma in situ):** Flat, high‑grade, and more aggressive in behaviour

Initial treatment involves Transurethral Resection of Bladder Tumour (TURBT), followed by intravesical (into the bladder) therapy to reduce recurrence.

When It's Needed

Treatment is tailored based on risk category:

  • Low risk: Single, small, low‑grade tumour – TURBT plus single dose intravesical chemotherapy (e.g. mitomycin)

  • Intermediate risk: Multiple or recurrent low‑grade tumours – induction and maintenance intravesical therapy

  • High risk: High‑grade or CIS – induction and maintenance Bacillus Calmette‑Guérin (BCG) therapy, or in selected cases, early cystectomy

Surgery Diagram

Benefits

  • Organ-preserving treatment in most cases

  • High survival rates (>95% for low-risk NMIBC)

  • Outpatient, minimally invasive treatment

  • BCG therapy reduces recurrence by ≈60%

Risks

  • Tumour recurrence - 30-70% depending on risk group

  • Progression to muscle-invasive disease (≈10-20% overall, higher for high-grade tumours)

  • Irritative urinary symptoms during intravesical therapy

  • Rare bladder contraction or systemic infection from BCG (<1%)

What to Expect After Treatment

You will have regular cystoscopies (usually every 3-6 months initially) to check for recurrence. Some patients receive a short course of intravesical chemotherapy or immunotherapy after surgery. Mild discomfort and urgency are common after treatments but settle quickly.

FAQs

  • Yes - most NMIBC cases are curable with endoscopic and intravesical treatments.

  • Because recurrence is common, ongoing cystoscopic surveillance ensures early detection and treatment.

  • Recurrences are usually treated with repeat TURBT and/or further bladder instillations.

Discover Expert Urological Care

I specialise in precision urology using the latest robotic and minimally invasive techniques. Explore my approach, my procedures, and the care I provide at every stage of your journey.

About Dr. David Wetherell

Contact Dr. David Wetherell